These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23859342)

  • 1. Animal and cellular models of Friedreich ataxia.
    Perdomini M; Hick A; Puccio H; Pook MA
    J Neurochem; 2013 Aug; 126 Suppl 1():65-79. PubMed ID: 23859342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues.
    Al-Mahdawi S; Pinto RM; Ismail O; Varshney D; Lymperi S; Sandi C; Trabzuni D; Pook M
    Hum Mol Genet; 2008 Mar; 17(5):735-46. PubMed ID: 18045775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of mismatch repair enzymes in GAA·TTC triplet-repeat expansion in Friedreich ataxia induced pluripotent stem cells.
    Du J; Campau E; Soragni E; Ku S; Puckett JW; Dervan PB; Gottesfeld JM
    J Biol Chem; 2012 Aug; 287(35):29861-72. PubMed ID: 22798143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell models.
    Sandi C; Sandi M; Jassal H; Ezzatizadeh V; Anjomani-Virmouni S; Al-Mahdawi S; Pook MA
    PLoS One; 2014; 9(2):e89488. PubMed ID: 24586819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond loss of frataxin: the complex molecular pathology of Friedreich ataxia.
    Evans-Galea MV; Lockhart PJ; Galea CA; Hannan AJ; Delatycki MB
    Discov Med; 2014 Jan; 17(91):25-35. PubMed ID: 24411698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiogical and therapeutic progress in Friedreich ataxia.
    Puccio H; Anheim M; Tranchant C
    Rev Neurol (Paris); 2014 May; 170(5):355-65. PubMed ID: 24792433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology.
    Al-Mahdawi S; Pinto RM; Varshney D; Lawrence L; Lowrie MB; Hughes S; Webster Z; Blake J; Cooper JM; King R; Pook MA
    Genomics; 2006 Nov; 88(5):580-90. PubMed ID: 16919418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Friedreich ataxia: an update on animal models, frataxin function and therapies.
    González-Cabo P; Llorens JV; Palau F; Moltó MD
    Adv Exp Med Biol; 2009; 652():247-61. PubMed ID: 20225031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Friedreich ataxia with GAA repeat expansion: molecular mechanism and clinical feature].
    Tanaka H
    Nihon Rinsho; 1999 Apr; 57(4):960-6. PubMed ID: 10222797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia.
    Greene E; Mahishi L; Entezam A; Kumari D; Usdin K
    Nucleic Acids Res; 2007; 35(10):3383-90. PubMed ID: 17478498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long intronic GAA*TTC repeats induce epigenetic changes and reporter gene silencing in a molecular model of Friedreich ataxia.
    Soragni E; Herman D; Dent SY; Gottesfeld JM; Wells RD; Napierala M
    Nucleic Acids Res; 2008 Nov; 36(19):6056-65. PubMed ID: 18820300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation in intron 1 of the frataxin gene is related to GAA repeat length and age of onset in Friedreich ataxia patients.
    Castaldo I; Pinelli M; Monticelli A; Acquaviva F; Giacchetti M; Filla A; Sacchetti S; Keller S; Avvedimento VE; Chiariotti L; Cocozza S
    J Med Genet; 2008 Dec; 45(12):808-12. PubMed ID: 18697824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia.
    Sarsero JP; Li L; Wardan H; Sitte K; Williamson R; Ioannou PA
    J Gene Med; 2003 Jan; 5(1):72-81. PubMed ID: 12516053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures.
    Lai JI; Nachun D; Petrosyan L; Throesch B; Campau E; Gao F; Baldwin KK; Coppola G; Gottesfeld JM; Soragni E
    J Biol Chem; 2019 Feb; 294(6):1846-1859. PubMed ID: 30552117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecules affecting transcription in Friedreich ataxia.
    Gottesfeld JM
    Pharmacol Ther; 2007 Nov; 116(2):236-48. PubMed ID: 17826840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GAA repeat instability in Friedreich ataxia YAC transgenic mice.
    Al-Mahdawi S; Pinto RM; Ruddle P; Carroll C; Webster Z; Pook M
    Genomics; 2004 Aug; 84(2):301-10. PubMed ID: 15233994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicellular models of Friedreich ataxia.
    Puccio H
    J Neurol; 2009 Mar; 256 Suppl 1():18-24. PubMed ID: 19283346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular, molecular and functional characterisation of YAC transgenic mouse models of Friedreich ataxia.
    Anjomani Virmouni S; Sandi C; Al-Mahdawi S; Pook MA
    PLoS One; 2014; 9(9):e107416. PubMed ID: 25198290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Friedreich's ataxia: from disease mechanisms to therapeutic interventions.
    Lodi R; Tonon C; Calabrese V; Schapira AH
    Antioxid Redox Signal; 2006; 8(3-4):438-43. PubMed ID: 16677089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Friedreich's ataxia: past, present and future.
    Marmolino D
    Brain Res Rev; 2011 Jun; 67(1-2):311-30. PubMed ID: 21550666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.